Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
BioNTech
BNTX
$29.3B
| $43.1M | 0.05% |
463,163
+369,708
| +396% | +$34.8M |
|
|
SGI
402
Somnigroup International
SGI
$13.6B
| $43M | 0.05% |
549,036
+355,309
| +183% | +$26M |
|
403
CALL
State Street SPDR S&P Bank ETF
KBE
$1.74B
| $42.7M | 0.05% |
+626,200
| New | +$40.1M |
|
404
CALL
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
| $42.6M | 0.05% |
200,000
+79,300
| +66% | +$16.2M |
|
405
Madrigal Pharmaceuticals
MDGL
$11.9B
| $42.4M | 0.05% |
+79,011
| New | +$40.5M |
|
|
DFTX
406
Definium Therapeutics
DFTX
$6.03B
| $42.2M | 0.05% |
897,658
-376,563
| -30% | -$9.31M |
|
407
Public Service Enterprise Group
PEG
$36.2B
| $42.1M | 0.05% |
518,442
+510,458
| +6,394% | +$40.8M |
|
|
408
CALL
Meta Platforms (Facebook)
META
$1.4T
| $41.9M | 0.05% |
74,400
-414,500
| -85% | -$253M |
|
409
Ulta Beauty
ULTA
$22.4B
| $41.9M | 0.05% |
92,861
+74,130
| +396% | +$37.6M |
|
410
PUT
Wells Fargo
WFC
$254B
| $41.7M | 0.05% |
504,700
+2,400
| +0.5% | +$193K |
|
411
Linde
LIN
$225B
| $41.5M | 0.05% |
79,911
+70,950
| +792% | +$35.9M |
|
412
Modine Manufacturing
MOD
$10.5B
| $41.4M | 0.05% |
155,079
-111,034
| -42% | -$29.3M |
|
413
Duke Energy
DUK
$93.4B
| $41.4M | 0.05% |
326,944
+315,110
| +2,663% | +$39.7M |
|
414
Edwards Lifesciences
EW
$51.8B
| $41.3M | 0.05% |
456,202
+446,204
| +4,463% | +$37.4M |
|
415
Jefferies Financial Group
JEF
$12.1B
| $41M | 0.05% |
820,771
+292,187
| +55% | +$15.1M |
|
416
Comcast
CMCSA
$95.3B
| $40.9M | 0.05% |
1,664,267
+1,610,707
| +3,007% | +$41.6M |
|
417
CALL
Alibaba
BABA
$286B
| $40.2M | 0.05% |
419,200
+121,000
| +41% | +$15.2M |
|
418
PUT
Micron Technology
MU
$1.09T
| $40.2M | 0.05% |
34,800
-113,200
| -76% | -$84.9M |
|
419
Sysco
SYY
$40.2B
| $40.1M | 0.05% |
480,008
-799,614
| -62% | -$60.5M |
|
420
Gartner
IT
$12.4B
| $40M | 0.05% |
308,288
+299,314
| +3,335% | +$45.1M |
|
421
Teleflex
TFX
$5.88B
| $40M | 0.05% |
315,212
-86,205
| -21% | -$11M |
|
422
CALL
Rivian
RIVN
$24.6B
| $39.8M | 0.05% |
2,294,300
+63,600
| +3% | +$992K |
|
423
Alcoa
AA
$13.7B
| $39.5M | 0.05% |
757,389
+671,178
| +779% | +$44.9M |
|
|
SCHW
424
PUT
Charles Schwab
SCHW
$194B
| $39.4M | 0.05% |
427,300
-51,800
| -11% | -$4.72M |
|
|
VG
425
Venture Global Inc
VG
$35.5B
| $39.4M | 0.05% |
3,540,269
+3,496,567
| +8,001% | +$44.2M |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.